Back to Selection     Print       Date : 31 Mar 2025
Fund Summary
ICICI Pru Pharma Healthcare And Diagnostics Fund (G)
[Equity: Sectoral]  
 
Fund Details
Fund Type Growth Launch Date 13-Jul-2018
Corpus(Cr.) 4915.0 Latest NAV 38.54 As on 30-05-2025
Equity(%) 98.3 52 Week High 40.39
Debt(%) 1.7 52 Week Low 30.13
Others(%) 0.0 Exit Load 1% for redemption within 15 days
Minimum Investment - Availability
Entry Load Nil Expense Ratio(%) 1.94
Scheme Benchmark BSE Healthcare TRI Broader Benchmark NSE - Nifty 50 TRI
Fund Manager Dharmesh Kakkad
 
Riskometer
Investors understand that their principal will be at Very High risk
 
Scheme Objective
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.

Portfolio Classification
 
Asset Mix
 
Concentration Analysis
Top 5 Holdings 43.31%
Top 10 Holdings 62.45%
Top 25 Holdings 86.91%
 
Sector Analysis
Sector/Ratings Net Asset(%)
Pharma & Biotech 80.78
Healthcare 7.16
Chemicals 4.54
Miscellaneous 4.28
Cash 1.7
Retail 1.54
 
 
 
 
 
Portfolio Metrics
PB Ratio 4.20
PE Ratio 31.08
 
Top 25 Holdings
Holdings Net Asset(%)
Sun Pharmaceutical Industries Limited 13.50
Dr Reddys Laboratories Limited 8.95
Cipla Limited 8.85
DIVI LABORATORIES LTD 6.71
Aurobindo Pharma Limited 5.30
Lupin Limited 4.73
Alkem Laboratories Limited 4.42
MANKIND PHARMA LIMITED 3.50
Gland Pharma Limited 3.39
Zydus Lifesciences Limited 3.10
Apollo Hospitals Enterprise Limited 2.82
Syngene International Limited 2.11
Atul Limited 1.93
WINDLAS BIOTEC LTD 1.82
Pfizer Limited 1.77
ALEMBIC PHARMACEUTICALS 1.65
MEDPLUS HEALTH SERVICES LIMITED 1.54
SBI Life Insurance Co Ltd 1.48
Biocon Limited 1.44
ADVANCED ENZYME TECHNOLOGIE LT 1.43
TREPS 1.41
Medi Assist Healthcare Services Limited 1.35
Shilpa Medicare Limited 1.30
EQ -FINE ORGANIC IND LTD 1.22
Glenmark Pharmaceuticals Limited 1.19

Performance Analysis
 
Short Terms Returns
1 Month 3 Month 6 Month 1 Year
3.24% 14.02% 0.10% 25.62%
 
Broader Market Benchmark [NSE - Nifty 50 TRI]
1.92% 12.13% 3.05% 11.08%
 
Scheme Benchmark [BSE Healthcare TRI]
 
Long term Returns
2 Year 3 Year 5 Year 10 Year
38.64% 27.72% 25.57% 0.00%
 
 
16.89% 15.56% 22.29% 12.73%
 
 
 
Cumulative Performance of Last 5 Years
 
Calendar Year Returns

Risk Analysis
 
Absolute Metrics (Single Computation - last 3 years)
Scheme Name Standard Deviation Sharpe Ratio Downside Deviation Downside Probability Sortino Ratio
 
Benchmark Relative Metrics (Single Computation - last 3 years)
Scheme Name Alpha Beta Treynor Ratio Tracking Error Information Ratio
 
Back to Selection